Collaboration across (baseball) fields leads to Amazonian rivers

An ambitious project that deploys big data and uses machine learning to understand the ecological impacts of hydropower dams in the Amazon Basin started in a mundane enough setting: on the sidelines at youth baseball games.

'Eelevator' project gives American eels a lift

An 'eelevator' designed and built by a team including Cornell researchers is helping American eels survive their journey from the Atlantic Ocean to the Hudson River and the rivers of the East Coast.

Bringing bacteria's defense into focus

By taking a series of near-atomic resolution snapshots, Cornell and Harvard Medical School scientists have observed step-by-step how bacteria defend against foreign invaders.

Discovering the early age immune response in foals

Researchers at the College of Veterinary Medicine have discovered a new method to measure tiny amounts of antibodies in foals, a finding described in the May 16 issue of PLOS ONE.

New discovery holds potential as tuberculosis drug

College of Veterinary Medicine researchers have discovered a key metabolic mechanism in Mycobacterium tuberculosis bacteria, which presents a novel drug target for potentially treating tuberculosis.

Enzyme key to triggering anti-cancer immune response

An enzyme implicated in autoimmune diseases and viral infections also regulates radiation therapy's ability to trigger an immune response against cancer, Weill Cornell Medicine scientists found in a new study.

Cornell to team with IBM to protect global milk supply

Cornell and IBM announced a joint research project June 23 that will use genetic sequencing and big-data analyses to help keep the global milk supply safe.

Cohen wins Gates grant for her new take on male contraception

Geneticist Paula Cohen has won $100,000 Gates Foundation grant to develop a radical approach to contraception: preventing the sperm cell from developing, before it ever reaches the egg. She was chosen from 1,600 applicants.

Human tissue model developed to test colon cancer drugs

The first-ever 'disease in a Petri dish' platform that models human colon cancer derived from stem cells has been developed by Weill Cornell Medicine investigators, allowing them to identify a targeted drug treatment for a common, inherited form of the disease.